CIRCASSIA LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 25230
 
 
 
C07K PEPTIDES 14122
 
 
 
B01J CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS, COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 4105
 
 
 
B01D SEPARATION 3131
 
 
 
C30B SINGLE-CRYSTAL GROWTH 353
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
 
 
B01F MIXING, e.g. DISSOLVING, EMULSIFYING, DISPERSING 141
 
 
 
B06B GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS IN GENERAL 123

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0275,781 PROCESS FOR IMPROVING CRYSTALLINITYApr 18, 17Sep 28, 17[A61K, C30B, B01D]
2015/0352,077 Multi-Component Crystalline Particles for Inhalation TherapyJan 29, 14Dec 10, 15[A61K, A61M]
2015/0218,215 CLADOSPORIUM PEPTIDESMay 30, 13Aug 06, 15[A61K, G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9850281 Cladosporium peptidesMay 30, 13Dec 26, 17[A61K, G01N, C07K]
9744222 Peptide for vaccineOct 17, 16Aug 29, 17[A61K, C07K]
9682038 Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapyJan 29, 14Jun 20, 17[A61K]
9657061 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapyMay 09, 13May 23, 17[A61K, C07K]
9637840 Process for improving crystallinityJul 20, 09May 02, 17[A61K, C30B, B32B, B01D]
9375470 Compositions with reduced dimer formationOct 06, 15Jun 28, 16[A61K, C07K]
9347937 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergyJun 14, 13May 24, 16[A61K, G01N, C07K]
9340580 Peptide with multiple epitopesAug 15, 08May 17, 16[A61K, G01N, C07K]
9278323 Process for making crystalsJun 17, 08Mar 08, 16[A61K, B01J, B01D]
9220708 Pharmaceutical compositionsAug 08, 12Dec 29, 15[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0289,281 PEPTIDE WITH MULTIPLE EPITOPESAbandonedApr 11, 16Oct 06, 16[C07K]
2016/0120,965 VACCINE PEPTIDE COMBINATIONS AGAINST CAT ALLERGYAbandonedSep 11, 15May 05, 16[A61K]
2016/0081,924 PHARMACEUTICAL COMPOSITIONSAbandonedNov 25, 15Mar 24, 16[A61K, A61M]
2015/0196,635 PEPTIDES FOR VACCINE AGAINST BIRCH ALLERGYAbandonedMar 31, 15Jul 16, 15[A61K, G01N]
2015/0098,969 ALTERNARIA PEPTIDESAbandonedMay 30, 13Apr 09, 15[A61J, G01N, C07K]
2014/0328,868 T-CELL ANTIGEN PEPTIDE FROM ALLERGEN FOR STIMULATION OF IL-10 PRODUCTIONAbandonedMay 02, 14Nov 06, 14[A61K]
2014/0302,071 PEPTIDES FOR VACCINEAbandonedMay 19, 14Oct 09, 14[A61K]
2014/0186,403 PEPTIDE FOR VACCINEAbandonedJan 08, 14Jul 03, 14[A61K, C07K]
2013/0336,999 PEPTIDE WITH REDUCED DIMER FORMATIONAbandonedAug 23, 13Dec 19, 13[A61K, C07K]
2011/0038,881 PROGNOSTIC ASSAY FOR DETERMINING T CELL RESPONSE TO HLA ANTIGENS AND USE THEREOF IN FIELD OF TISSUE TRANSPLANTATIONAbandonedMay 09, 08Feb 17, 11[A61K, G01N, A61P]
2006/0084,789 Immunotherapeutic and immunoprphylactic reagentsAbandonedApr 02, 03Apr 20, 06[A61K, C07K]
2006/0024,334 Immunotherapeutic methods and systemsAbandonedDec 05, 02Feb 02, 06[A61K]
2005/0075,481 T cell epitopes of the cyn d 1 allergen from bermuda grass pollenAbandonedSep 15, 04Apr 07, 05[C07K]
2004/0265,342 Methods and compositions for desensitisationAbandonedMar 25, 04Dec 30, 04[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.